By-health Co., Ltd. (300146.SZ)
CNY 12.76
(-0.39%)
CNY 12.76
(-0.39%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 2.14 Billion | 1.37 Billion | 1.81 Billion | 1.56 Billion | 1.53 Billion | 1.34 Billion |
| Net Income | 1.74 Billion | 1.41 Billion | 1.76 Billion | 1.54 Billion | -415.04 Million | 908.43 Million |
| Depreciation & Amortization | 244.42 Million | 243.78 Million | 245.66 Million | 205.21 Million | 248.99 Million | 147.34 Million |
| Deferred income taxes | -49.4 Million | -63.11 Million | -3.23 Million | -55.4 Million | -265.43 Million | -35.15 Million |
| Stock-based compensation | - | -38.05 Million | -7.27 Million | 16.42 Million | 32.13 Million | 2.54 Million |
| Change in working capital | 199.45 Million | -261.44 Million | -29.92 Million | 181.52 Million | -62.09 Million | 232.17 Million |
| Other non-cash items | 291.79 Million | 86.48 Million | -152.54 Million | -325.48 Million | 1.99 Billion | 61.09 Million |
| Investing Cash Flow | -1.41 Billion | -131.27 Million | -2.35 Billion | -531.76 Million | -249.2 Million | -4.04 Billion |
| Investments in PPE | -1.25 Billion | -244.77 Million | -263.16 Million | -321.69 Million | -331.84 Million | -250.68 Million |
| Acquisitions | 705.86 Thousand | 2.94 Million | 267.36 Million | 2.44 Million | 162.08 Thousand | -3.31 Billion |
| Investment purchases | -5.99 Billion | -6.11 Billion | -4.19 Billion | -2.35 Billion | -1.48 Billion | -3.78 Billion |
| Sales/Maturities of investments | 5.88 Billion | 6.23 Billion | 2.09 Billion | 2.04 Billion | 1.57 Billion | 3.31 Billion |
| Other Investing Activities | -50 Million | -999.99 Thousand | -263.16 Million | 98.05 Million | -381.07 Thousand | 424.86 Thousand |
| Financing Cash Flow | -372.2 Million | -1.22 Billion | 1.64 Billion | -949.6 Million | -1.26 Billion | 1.74 Billion |
| Debt repayment | -35.62 Million | -37.33 Million | -255.89 Million | -583.66 Million | -1.18 Billion | -106.46 Million |
| Dividends payments | -306.08 Million | -1.19 Billion | -1.1 Billion | -569.69 Million | -734.35 Million | -503.82 Million |
| Common Stock Repurchased | -17.99 Million | - | 1.32 Million | -7.21 Million | - | -33.75 Million |
| Common Stock Issuance | - | - | -1.32 Million | 7.21 Million | - | - |
| Other Financing Activities | -48.12 Million | 358.71 Thousand | 3.01 Billion | 228.05 Million | 697.03 Million | 2.35 Billion |
| Accounts receivables | -61.82 Million | -160.47 Million | -88.5 Million | -88.79 Million | 304.2 Million | 134.36 Million |
| Accounts payables | 362.63 Million | 41.09 Million | 39.25 Million | 390.6 Million | -6.32 Million | 163.44 Million |
| Inventory | -102.54 Million | -78.94 Million | 22.56 Million | -64.87 Million | -94.54 Million | -30.48 Million |
| Other working capital | 1.19 Million | -63.11 Million | -3.23 Million | -55.4 Million | -265.43 Million | 262.66 Million |
| Cash at beginning of period | 2.96 Billion | 2.9 Billion | 1.82 Billion | 1.74 Billion | 1.72 Billion | 2.64 Billion |
| Cash at end of period | 3.32 Billion | 2.95 Billion | 2.9 Billion | 1.82 Billion | 1.74 Billion | 1.72 Billion |
| Capital Expenditure | -1.25 Billion | -244.77 Million | -263.16 Million | -321.69 Million | -331.84 Million | -250.68 Million |
| Effect of forex changes on cash | 13.03 Million | 37.9 Million | -34.03 Million | -3.79 Million | 1.58 Million | 19.16 Million |
| Net cash flow / Change in cash | 366.39 Million | 58.25 Million | 1.07 Billion | 81.2 Million | 23.84 Million | -928.69 Million |
| Free Cash Flow | 884.66 Million | 1.13 Billion | 1.55 Billion | 1.24 Billion | 1.2 Billion | 1.09 Billion |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -22.41 Million | 164.47 Million | 726.55 Million | 1.74 Billion | -154.79 Million | 355.7 Million |
| Depreciation & Amortization | - | 63.23 Million | 63.23 Million | 244.42 Million | 61.22 Million | -114.68 Million |
| Deferred income taxes | - | - | - | -49.4 Million | - | - |
| Stock-based compensation | - | 24.28 Million | - | - | - | - |
| Change in working capital | - | 264.52 Million | - | 199.45 Million | -163.17 Million | 141.94 Million |
| Other non-cash items | 107.11 Million | 81.46 Million | -553.89 Million | 291.79 Million | 1 Billion | -76.85 Million |
| Investing Cash Flow | -580.2 Million | 668.99 Million | -191.8 Million | -1.41 Billion | 193.06 Million | -78.59 Million |
| Investments in PPE | -69.25 Million | -61.93 Million | -96.32 Million | -1.25 Billion | -80.09 Million | -72.17 Million |
| Acquisitions | 28.78 Thousand | 917.41 Thousand | 68.63 Thousand | 705.86 Thousand | 36.36 Thousand | 580.02 Thousand |
| Investment purchases | -1.39 Billion | -2.38 Billion | -1.8 Billion | -5.99 Billion | -1.37 Billion | -570 Million |
| Sales/Maturities of investments | 1.16 Billion | 3.11 Billion | 1.7 Billion | 5.88 Billion | 1.66 Billion | 562.99 Million |
| Other Investing Activities | -282.95 Million | 768.67 Million | -72.22 Million | -50 Million | -10 Million | 0.24 |
| Financing Cash Flow | 519.38 Million | -1.55 Billion | -202.41 Million | -372.2 Million | -30.79 Million | -831.46 Thousand |
| Debt repayment | -544.65 Million | - | - | -35.62 Million | - | - |
| Dividends payments | -1.51 Billion | -1.51 Billion | - | -306.08 Million | - | - |
| Common Stock Repurchased | 231.71 Million | -231.71 Million | - | -17.99 Million | -17.99 Million | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | 519.38 Million | 196.03 Million | -202.41 Million | -48.12 Million | -12.8 Million | -831.46 Thousand |
| Accounts receivables | - | -70.93 Million | - | -61.82 Million | -61.82 Million | 238.49 Million |
| Accounts payables | - | - | - | 362.63 Million | - | - |
| Inventory | - | 311.17 Million | - | -102.54 Million | -102.54 Million | -96.55 Million |
| Other working capital | - | 24.28 Million | - | 1.19 Million | 1.19 Million | - |
| Cash at beginning of period | 2.39 Billion | 3.09 Billion | 3.32 Billion | 2.96 Billion | 2.41 Billion | 2.19 Billion |
| Cash at end of period | 2.38 Billion | 2.39 Billion | 3.09 Billion | 3.32 Billion | 3.32 Billion | 2.41 Billion |
| Capital Expenditure | -69.25 Million | -61.93 Million | -96.32 Million | -1.25 Billion | -80.09 Million | -72.17 Million |
| Effect of forex changes on cash | -4.46 Million | 11.22 Million | -9.73 Million | 13.03 Million | 555.95 Thousand | -9.34 Million |
| Net cash flow / Change in cash | -18.62 Million | -692.93 Million | -234.96 Million | 366.39 Million | 908.75 Million | 217.33 Million |
| Free Cash Flow | 15.44 Million | 120.76 Million | 76.34 Million | 884.66 Million | 667.89 Million | 233.93 Million |
002050
CDG
300840
600052
3658
CRBU